17.1 CMS Coverage Guidelines, Qualifying Diagnoses & Practitioner Supervision

17.1 CMS Coverage Guidelines, Qualifying Diagnoses & Practitioner Supervision

[!NOTE] Regulatory Framework: Outpatient cardiac rehabilitation (CR) reimbursement under Medicare Part B is governed by statutory law under the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008, codified in the Code of Federal Regulations at 42 CFR § 410.49, and interpreted clinically through the Centers for Medicare & Medicaid Services (CMS) National Coverage Determination (NCD) 20.10. Adherence to these strict qualifying criteria and supervisory mandates is required to prevent claim denials, recoupments, and False Claims Act liability.

Cardiac rehabilitation is an evidence-based secondary prevention model proven to reduce all-cause mortality by 20% to 30%, decrease hospital readmissions, and enhance functional capacity. However, federal reimbursement is strictly conditioned on compliance with statutory diagnostic indications, session utilization limits, and medical oversight standards. Clinical professionals preparing for the CCRP examination must master the precise diagnostic thresholds, session parameters, and direct supervision rules governing Phase II outpatient programs.

---

Statutory Authority & Qualifying Indications

Under 42 CFR § 410.49 and CMS NCD 20.10, Medicare Part B reimburses outpatient cardiac rehabilitation services exclusively for patients who meet one of seven distinct clinical qualifying diagnoses:

1. Acute Myocardial Infarction (AMI): Must have occurred within the preceding 12 months prior to the date of starting cardiac rehabilitation. Any documented ST-elevation MI (STEMI) or non-ST-elevation MI (NSTEMI) within 365 calendar days satisfies this criterion.
2. Coronary Artery Bypass Graft (CABG) Surgery: Surgical myocardial revascularization utilizing arterial (e.g., internal mammary artery) or venous grafts. Unlike AMI, CMS statute does not impose a strict 12-month cutoff for CABG; however, enrollment typically commences 4 to 8 weeks postoperatively following sternal stabilization.
3. Current Stable Angina Pectoris: Requires documented objective clinical evidence of myocardial ischemia. Acceptable medical documentation includes positive stress electrocardiography, stress echocardiography, nuclear myocardial perfusion imaging, cardiac magnetic resonance, or angiographic demonstration of flow-limiting coronary stenoses with persistent exertional symptoms classified under Canadian Cardiovascular Society (CCS) Class II, III, or IV.
4. Heart Valve Repair or Replacement: Surgical or transcatheter repair or replacement of one or more cardiac valves (aortic, mitral, tricuspid, or pulmonary). This includes surgical mechanical or bioprosthetic valve replacement, Transcatheter Aortic Valve Replacement (TAVR), and Transcatheter Edge-to-Edge Repair (TEER, such as MitraClip).
5. Percutaneous Coronary Intervention (PCI): Transluminal coronary revascularization via balloon angioplasty, rotational or orbital atherectomy, or intracocoronary stent implantation (drug-eluting or bare-metal stents).
6. Heart Transplant or Heart-Lung Transplant: Orthotopic or heterotopic heart transplantation, or combined heart-lung transplantation, for end-stage cardiopulmonary disease.
7. Stable Chronic Heart Failure (HFrEF): Added via CMS national coverage expansion in 2014, heart failure qualifies only when meeting all four specific criteria:
   • Documented Left Ventricular Ejection Fraction (LVEF) <= 35% (heart failure with reduced ejection fraction) by echocardiography, radionuclide ventriculography, or cardiac MRI.
   • New York Heart Association (NYHA) Class II, III, or IV functional symptoms.
   • Maintained on stable optimal guideline-directed medical therapy (GDMT)—including beta-blockers, ACE inhibitors/ARBs/ARNIs, aldosterone antagonists, and SGLT2 inhibitors—for at least 6 weeks prior to initiating rehabilitation.
   • Clinically stable condition, defined as having had no hospitalizations for cardiovascular reasons and no planned major cardiovascular procedures within the preceding 6 weeks.

Non-Covered Diagnoses and Common Audit Traps

Medicare does not cover cardiac rehabilitation for several prevalent cardiovascular conditions, even when clinically beneficial. Common non-covered conditions include:

• Isolated permanent pacemaker or implantable cardioverter-defibrillator (ICD) implantation in the absence of a separate qualifying diagnosis (such as HFrEF with LVEF <=35% or recent AMI).
• Heart Failure with Preserved Ejection Fraction (HFpEF; LVEF >35%).
• Congenital heart disease, hypertrophic cardiomyopathy, or thoracic aortic aneurysm repair (unless accompanied by a covered valve or CABG procedure).
• Unstable angina pectoris (represents an absolute contraindication to exercise).
• Peripheral Artery Disease (PAD): Covered under a separate, distinct CMS benefit—Supervised Exercise Therapy (SET) for Symptomatic PAD (NCD 20.33)—which has its own distinct billing codes (CPT 93668) and supervisory rules.

---

Session Allowances: Standard CR vs. Intensive CR (ICR)

CMS establishes explicit session caps, daily frequency limits, and longitudinal time frames under 42 CFR § 410.49:

For standard Phase II CR, the statutory maximum is 36 sessions. A program may request an additional 36 sessions (up to 72 sessions total) only if the Medicare Administrative Contractor (MAC) determines that additional sessions are medically necessary (e.g., extreme deconditioning following prolonged critical illness), though routine approvals are rare.

---

Direct Physician Supervision Requirements

Under 42 CFR § 410.49, cardiac rehabilitation services must be furnished under direct supervision. Effective January 1, 2024, the supervising practitioner may be a physician (MD or DO) or a nonphysician practitioner — a physician assistant, nurse practitioner, or clinical nurse specialist — following the CY 2024 Physician Fee Schedule final rule codifying Section 51008 of the Bipartisan Budget Act of 2018. A physician still serves as the program medical director. Direct supervision requires:

1. The "Immediately Available and Accessible" Mandate

• Immediate Availability: The supervising practitioner must be immediately available and accessible for medical consultations and emergency interventions at all times when patients are receiving cardiac rehabilitation services. Direct supervision does not require presence in the exercise room itself.
• Virtual Presence Is Permitted: Under 42 CFR § 410.27(a)(1)(iv)(B)(1), presence for the purpose of supervising cardiac, intensive cardiac, and pulmonary rehabilitation includes virtual presence through real-time audio/video communications technology (audio-only does not qualify). This is codified regulation text, not a temporary public health emergency waiver, so a supervising practitioner joining by real-time two-way video satisfies direct supervision.
• No Physical Encumbrances: The supervising practitioner cannot be performing an un-interruptible procedure (e.g., performing cardiac catheterization, major surgery, or endoscopy) that would prevent immediate physical arrival at the CR exercise pavilion in the event of a clinical emergency.
• Setting-Specific Rules: 42 CFR § 410.49(b)(3)(ii) defers to the incident-to supervision rules — § 410.26 for physician-office programs and § 410.27 for hospital outpatient departments. In a physician-office program the practitioner is present in the office suite; in a hospital outpatient department the practitioner is immediately available in the department, and in both settings the virtual-presence allowance above applies.

2. Supervising Practitioner Qualifications

Under 42 CFR § 410.49(e), a physician or nonphysician practitioner acting as the supervising practitioner must possess both of the following — and only these two are regulatory minimums:

• Expertise in the management of individuals with cardiac pathophysiology.
• Cardiopulmonary training in basic life support or advanced cardiac life support.

[!IMPORTANT] The regulation reads "basic life support or advanced cardiac life support," not "and." A common exam distractor asserts that both BLS and ACLS certification are federally mandated for the supervising practitioner. Most programs require ACLS as an internal policy and AACVPR Program Certification expects it of staff, but that is institutional policy, not 42 CFR § 410.49.

The medical director carries an additional requirement under § 410.49(d): the same cardiac expertise and BLS-or-ACLS training, plus licensure to practice medicine in the state where the program is offered.

3. Non-Physician Practitioners (NPPs)

Under statutory updates enacted through the Bipartisan Budget Act of 2018 (effective January 1, 2024), physician assistants (PAs), nurse practitioners (NPs), and clinical nurse specialists (CNSs) are legally permitted to furnish direct supervision for cardiac rehabilitation programs, provided they satisfy state scope of practice laws and program credentialing requirements.

---

Clinical & Administrative Matrix: CMS Qualifying Indications

---

Realistic Administrative Scenario: Heart Failure Audit Defense

Compliance Scenario: During an internal compliance audit of an outpatient cardiac rehabilitation department, the compliance officer flags a Medicare claim for a 68-year-old male enrolled under the chronic heart failure diagnosis. The chart contains an echocardiogram from 2 months prior documenting an LVEF of 30% and an intake note describing NYHA Class III dyspnea. However, further review reveals that 3 weeks prior to CR intake, the patient was admitted to the hospital for 48 hours for intravenous furosemide diuresis following acute decompensated heart failure. Additionally, his sacubitril/valsartan dose was adjusted from 24/26 mg to 49/51 mg upon discharge.

Regulatory Analysis & Corrective Action:

• Non-Compliance Finding: Under CMS NCD 20.10, the patient violates two mandatory coverage criteria: he experienced a cardiovascular hospitalization within the preceding 6 weeks, and his guideline-directed medical therapy has not been stable for at least 6 weeks.
• Financial Risk: Billing Medicare for sessions delivered under these circumstances constitutes an improper claim subject to full payment recoupment and potential administrative penalties.
• Corrective Action: The clinical team must defer Phase II exercise sessions until the patient has achieved 6 full weeks of clinical stability post-hospitalization on his current GDMT regimen. A formal re-evaluation note must be entered into the chart at week 6 confirming zero cardiovascular readmissions, stable diuretic and neurohormonal dosing, and persistent NYHA II-IV symptoms prior to initiating billable sessions.